CD5 and COVID-19: Focusing on cDC2s, an increase in frequencies of CD5+ DC2s was detected in moderate COVID-19 (Fig. 3 J and K), while a reduction in frequencies of CD163−CD14− DC3s was noted in severe COVID-19 with otherwise stable frequencies of the DC3 subsets (Fig. 3L).